Potassium Iodide → HCID 178470279, 화합물

HRID 1801906노트

반응식

HRID 1801906 반응식
Cl[C:2]1[C:11]2[C:6](=[CH:7][C:8]([I:12])=[CH:9][CH:10]=2)[N:5]=[C:4]([C:13]([O:15][CH2:16][CH3:17])=[O:14])[N:3]=1.[I-].[K+].CCN(C(C)C)C(C)C.[NH:29]1[CH:33]=[CH:32][C:31]([NH2:34])=[N:30]1>CN(C=O)C.O>[NH:29]1[CH:33]=[CH:32][C:31]([NH:34][C:2]2[C:11]3[C:6](=[CH:7][C:8]([I:12])=[CH:9][CH:10]=3)[N:5]=[C:4]([C:13]([O:15][CH2:16][CH3:17])=[O:14])[N:3]=2)=[N:30]1

참가 물질

7

반응물 4

HCID 4875Potassium IodideHCID 81531DiisopropylethylamineHCID 86649053Ethyl 4-chloro-7-iodoquinazoline-2-carboxylateHCID 178418806HCID 178418806, 화합물

생성물 1

HCID 178470279HCID 178470279, 화합물수율 84%

시약·촉매·용매 2

HCID 962Water용매HCID 6228Dimethylformamide용매

실험 절차

To a solution of ethyl 4-chloro-7-iodoquinazoline-2-carboxylate (0.138 g, 0.38 mmol) in DMF (2 mL) at rt under argon were added potassium iodide (0.069 g, 0.42 mmol), DIEA (0.079 mL, 0.45 mmol), and 1H-pyrazol-3-amine (0.038 g, 0.46 mmol). The mixture was stirred at rt overnight then diluted with H2O (15 mL). The precipitate was collected by filtration, washed with H2O, and dried under high vacuum for several hours to afford ethyl 4-(1H-pyrazol-3-ylamino)-7-iodoquinazoline-2-carboxylate as a yellow solid (0.130 g, 84%). 1H NMR (300 MHz, DMSO-d6) δ1.34 (t, 3H), 4.38 (q, 2H), 7.14 (m, 1H), 7.72 (m, 1H), 7.94 (d, 1H), 8.28 (d, 1H), 8.48 (d, 1H), 10.92 (s, 1H), 12.58 (s, 1H); LC-MS (ESI) m/z 410 (M+H)+.

후처리

  1. filtrationThe precipitate was collected by filtration
  2. washwashed with H2O
  3. customdried under high vacuum for several hours

출처 및 근거

ORD 기록
ord-dc0629ac2af54911a8cc2f12d61db43f
출처 데이터셋
uspto-grants-2013_01
특허 번호
US08349851B2

반응 노트

불러오는 중…